Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 26 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2018$150,000
-86.6%
254,330
-11.5%
0.00%
-100.0%
Q2 2018$1,122,000
+246.3%
287,300
+166.0%
0.00%
Q1 2018$324,000
+25.6%
108,000
+44.4%
0.00%
Q4 2017$258,000
+44.1%
74,800
+90.8%
0.00%
Q3 2017$179,000
-20.4%
39,200
-18.6%
0.00%
Q1 2017$225,00048,1510.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2017
NameSharesValueWeighting ↓
Virtu Financial LLC 22,133$13,0000.00%
A.R.T. Advisors, LLC 49,384$29,0000.00%
BANK OF AMERICA CORP /DE/ 4,909$3,0000.00%
WELLS FARGO & COMPANY/MN 3,100$2,0000.00%
NORTHERN TRUST CORP 12,480$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 2,550$2,0000.00%
PANAGORA ASSET MANAGEMENT INC 7,235$4,0000.00%
TWO SIGMA INVESTMENTS, LP 23,957$14,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 38,714$22,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders